Purdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis Post author:Sam Post published:February 12, 2018 Post category:BioPharma That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace You Might Also Like Bavarian Nordic Plummets 49% After Cancer Vaccine Flunks Late-Stage Test September 14, 2017 European Regulatory Committee Recommends Rejecting Puma Biotechnology’s Breast Cancer Medicine February 22, 2018 Biotech Startups Flock to the Suburbs Over Rising Rent Prices August 20, 2017
European Regulatory Committee Recommends Rejecting Puma Biotechnology’s Breast Cancer Medicine February 22, 2018